FDAnews
www.fdanews.com/articles/70286-praecis-provides-update-on-german-marketing-authorization

Praecis Provides Update on German Marketing Authorization

March 25, 2005

Praecis Pharmaceuticals provided an update on the status of its marketing authorization application (MAA) for Plenaxis in Germany. As previously disclosed, the company's MAA for Plenaxis is pending with German regulatory authorities. The company is evaluating, and will respond to, a recent communication and requests from the German Federal Institute for Drugs and Medical Devices (BfArM) regarding the MAA. The company has also been in discussions with its partner, Schering AG, regarding possible responses to the BfArM, and their potential impact on the scope of the label for Plenaxis should it be approved in Germany.

Yahoo News (http://biz.yahoo.com/bw/050324/245682_1.html)